|Articles|October 1, 2012

Retrospective: CleanRooms_Dixon

To view a PDF of this article from the BioPharm International archives, click this link

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

Molecular model of antibody taking part in immune defense. Molecule of immunoglobulin, 3D illustration | Image credit: © Dr_Microbe - © Dr_Microbe - stock.adobe.com

What a $2 Billion Maryland Expansion Means for the Future of Biologics Production

ByFeliza Mirasol

November 24th 2025

FAQ: What You Need to Know About Modern Vaccine Development and Compliance

ByFeliza Mirasol

November 21st 2025

Development and creation of coronavirus vaccine COVID-19 .Coronavirus Vaccine concept in hand of doctor blue vaccine jar. Vaccine Concept of fight against coronavirus. | Image credit: © Looker_Studio - © Looker_Studio - stock.adobe.com

CDC’s Policy Shift on Autism and Vaccines Spurs Biopharma Quality/System Concerns

ByFeliza Mirasol

November 21st 2025

A skilled technician examines a microfluidic device in a laboratory setting. | Image credit: © Vectplus - © Vectplus - stock.adobe.com

How Miniaturized Analytics Are Transforming Aseptic Bioprocessing Control

ByFeliza Mirasol

November 21st 2025

The Switch to Cell-Free DNA: Strategic and Regulatory Considerations for Advanced Therapies

By4basebio

November 19th 2025

Retrospective: CleanRooms_Dixon

Newsletter

Related Content

What a $2 Billion Maryland Expansion Means for the Future of Biologics Production

FAQ: What You Need to Know About Modern Vaccine Development and Compliance

CDC’s Policy Shift on Autism and Vaccines Spurs Biopharma Quality/System Concerns

How Miniaturized Analytics Are Transforming Aseptic Bioprocessing Control

The Switch to Cell-Free DNA: Strategic and Regulatory Considerations for Advanced Therapies

Trending on BioPharm International

Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery

Drug Digest: Biopharma Landscape Evolves Through Strategic Alliances and Technology Integration

What a $2 Billion Maryland Expansion Means for the Future of Biologics Production

BioPharm Weekly News Roundup—Week of Nov. 24, 2025

Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture